Clinical Trial Update: Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Yiqi Huoxue Huatan Granule for reducing mortality in COPD with chronic respiratory failure; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Respiratory Failure

Drugs mentioned

• Yiqi Huoxue Huatan Granule

Snippet

Sponsor: Peking University People's Hospital | Conditions: Chronic Obstructive Pulmonary Disease, Chronic Respiratory Failure | Phase 3 | Status: UNKNOWN